<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39553680</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>21</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>In-silico and in-vitro studies to identify potential inhibitors of SARS-CoV-2 spike protein from Omani medicinal plants.</ArticleTitle><Pagination><StartPage>e39649</StartPage><MedlinePgn>e39649</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e39649</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2024.e39649</ELocationID><Abstract><AbstractText>In the quest for novel therapeutic agents against SARS-CoV-2, the proposed study explores the potential of traditional Omani medicinal plants, focusing on the efficacy of natural ligands against the virus's Spike protein. Among 437 identified medicinal plants across Oman, 47 species that are documented for their traditional use in treating respiratory infections, with 30 species' ligands available were chosen for analysis. Molecular docking was performed using Autodock Vina on these ligands, yielding 406 unique ligands post-duplication removal. The binding affinities of target-ligand complexes were precisely determined, ranking them by interaction strength. This process identified Corilagin, a phytochemical from the Acalypha indica plant (locally known as Aeyan Al Aqrada), as the most promising inhibitor. Subsequent analyses using GROMACS for molecular dynamics simulation confirmed its binding stability and interaction dynamics of the Corilagin-protein complex. The in-vitro studies further validated Corilagin's inhibitory effect on SARS-CoV-2, demonstrating a remarkable 92 % inhibition at 0.5 mM concentration. Dilution studies to ascertain the IC<sub>50</sub> value revealed Corilagin's high potency at a micromolar level (IC<sub>50</sub> = 2.15 ± 0.13 μM), underscoring its potential as a drug candidate for SARS-CoV-2 treatment. These findings highlight the significance of ethnomedicine and in-silico methodologies in drug discovery, offering promising directions for future antiviral research.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Mahrami</LastName><ForeName>Nabras</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Genetic Center, Royal Hospital, Ministry of Health, Sultanate of Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Smitha Sunil Kumaran</ForeName><Initials>SSK</Initials><AffiliationInfo><Affiliation>Department of Computing and Electronics Engineering, Middle East College, Sultanate of Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Mawali</LastName><ForeName>Adhra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Quality Assurance and Planning, German University of Technology (GUtech), Sultanate of Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beema Shafreen</LastName><ForeName>Raja-Mohamed</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Dr Umayal Ramanathan College for Women, Karaikudi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ullah</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Natural and Medical Sciences Research Center, University of Nizwa, Sultanate of Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halim</LastName><ForeName>Sobia Ahsan</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Natural and Medical Sciences Research Center, University of Nizwa, Sultanate of Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Harrasi</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Natural and Medical Sciences Research Center, University of Nizwa, Sultanate of Oman.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivakumar</LastName><ForeName>Nallusamy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biology, Sultan Qaboos University, Sultanate of Oman.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aeyan Al Aqrada</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Corilagin</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Drug discovery</Keyword><Keyword MajorTopicYN="N">Ethnomedicine</Keyword><Keyword MajorTopicYN="N">In-silico</Keyword><Keyword MajorTopicYN="N">In-vitro</Keyword><Keyword MajorTopicYN="N">Molecular docking</Keyword><Keyword MajorTopicYN="N">Molecular dynamics simulation</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 spike protein</Keyword><Keyword MajorTopicYN="N">Sultanate of Oman</Keyword></KeywordList><CoiStatement>All the listed authors have read and approved the submitted manuscript. This manuscript/data, or parts thereof, has not been submitted for possible publication to another journal or that the work has previously been published elsewhere. The present study was performed according to international, national and institutional rules considering animal experiments, clinical studies and biodiversity rights.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39553680</ArticleId><ArticleId IdType="pmc">PMC11564015</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2024.e39649</ArticleId><ArticleId IdType="pii">S2405-8440(24)15680-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  Retrieved from WHO supports scientifically-proven traditional medicine. 2020, May 04. https://www.afro.who.int/news/who-supports-scientifically-proven-traditional-medicine?gclid=Cj0KCQjwuNemBhCBARIsADp74QQARuzCQjfTIbq0PzzfeZJLRXPROppgeP3N4kZ11jmOqwjjnMVKtX4aAkE0EALw_wcB</Citation></Reference><Reference><Citation>WHO  Retrieved from WHO establishes the global Centre for traditional medicine in India. 2022, March 25. https://www.who.int/news/item/25-03-2022-who-establishes-the-global-centre-for-traditional-medicine-in-india</Citation></Reference><Reference><Citation>Zarei S.M., Heydari M.R. COVID-19 crisis, herbal medicines, and natural products - concerns and suggestions. Jundishapur J. Nat. Pharm. Prod. 2022;17(Issue 2) doi: 10.5812/jjnpp-120872.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/jjnpp-120872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussmann R.W., Glenn A. Medicinal plants used in Peru for the treatment of respiratory disorders. Rev. Peru. Biol. 2010;17(3)</Citation></Reference><Reference><Citation>Jamal Q.M.S. Antiviral potential of plants against COVID-19 during outbreaks—an update. Int. J. Mol. Sci. 2022;23(Issue 21) doi: 10.3390/ijms232113564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232113564</ArticleId><ArticleId IdType="pmc">PMC9655040</ArticleId><ArticleId IdType="pubmed">36362351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadybekov A.v., Katritch V. Computational approaches streamlining drug discovery. Nature. 2023;616(Issue 7958) doi: 10.1038/s41586-023-05905-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05905-z</ArticleId><ArticleId IdType="pubmed">37100941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender B.J., Gahbauer S., Luttens A., Lyu J., Webb C.M., Stein R.M., Fink E.A., Balius T.E., Carlsson J., Irwin J.J., Shoichet B.K. Publisher Correction: a practical guide to large-scale docking. Nat. Protoc. 2022:10. doi: 10.1038/s41596-021-00650-x. 4799-4832), 10.1038/s41596-021-00597-z). In Nature Protocols (Vol. 17, Issue 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-021-00650-x</ArticleId><ArticleId IdType="pmc">PMC8522653</ArticleId><ArticleId IdType="pubmed">34561691</ArticleId></ArticleIdList></Reference><Reference><Citation>Agu P.C., Afiukwa C.A., Orji O.U., Ezeh E.M., Ofoke I.H., Ogbu C.O., Ugwuja E.I., Aja P.M. Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci. Rep. 2023;13(1) doi: 10.1038/s41598-023-40160-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-40160-2</ArticleId><ArticleId IdType="pmc">PMC10435576</ArticleId><ArticleId IdType="pubmed">37592012</ArticleId></ArticleIdList></Reference><Reference><Citation>Eberhardt J., Santos-Martins D., Tillack A.F., Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J. Chem. Inf. Model. 2021;61(8) doi: 10.1021/acs.jcim.1c00203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.1c00203</ArticleId><ArticleId IdType="pmc">PMC10683950</ArticleId><ArticleId IdType="pubmed">34278794</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott O., Olson A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31(2) doi: 10.1002/jcc.21334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.21334</ArticleId><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Friesner R.A., Banks J.L., Murphy R.B., Halgren T.A., Klicic J.J., Mainz D.T., Repasky M.P., Knoll E.H., Shelley M., Perry J.K., Shaw D.E., Francis P., Shenkin P.S. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 2004;47(7) doi: 10.1021/jm0306430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm0306430</ArticleId><ArticleId IdType="pubmed">15027865</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitencourt-Ferreira G., de Azevedo W.F. Methods in Molecular Biology. 2019. Docking with SwissDock. 2053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9752-7_12</ArticleId></ArticleIdList></Reference><Reference><Citation>Childers M.C., Daggett V. Insights from molecular dynamics simulations for computational protein design. In Molecular Systems Design and Engineering. 2017;2(Issue 1) doi: 10.1039/c6me00083e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c6me00083e</ArticleId><ArticleId IdType="pmc">PMC5321087</ArticleId><ArticleId IdType="pubmed">28239489</ArticleId></ArticleIdList></Reference><Reference><Citation>Pronk S., Páll S., Schulz R., Larsson P., Bjelkmar P., Apostolov R., Shirts M.R., Smith J.C., Kasson P.M., van der Spoel D., Hess B., Lindahl E. Gromacs 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics. 2013;29(7) doi: 10.1093/bioinformatics/btt055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt055</ArticleId><ArticleId IdType="pmc">PMC3605599</ArticleId><ArticleId IdType="pubmed">23407358</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A.K., Singh A., Singh R., Misra A. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2021. Molnupiravir in COVID-19: a systematic review of literaturef. 15, Issue 6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102329</ArticleId><ArticleId IdType="pmc">PMC8556684</ArticleId><ArticleId IdType="pubmed">34742052</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava S., He F., Huang Y., Niu M., Adholeya A., Peng W.K. A brief review on medicinal plants-at-arms against COVID-19. Interdisciplinary Perspectives on Infectious Diseases. 2023;2023 doi: 10.1155/2023/7598307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/7598307</ArticleId><ArticleId IdType="pmc">PMC10151152</ArticleId><ArticleId IdType="pubmed">37139479</ArticleId></ArticleIdList></Reference><Reference><Citation>Teka A., Maryo M. Ethiopian medicinal plants used for respiratory tract disorders: ethnomedicinal review. Evid. base Compl. Alternative Med. 2023;2023 doi: 10.1155/2023/7612804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/7612804</ArticleId><ArticleId IdType="pmc">PMC9845041</ArticleId><ArticleId IdType="pubmed">36660273</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyagumbo E., Pote W., Shopo B., Nyirenda T., Chagonda I., Mapaya R.J., Maunganidze F., Mavengere W.N., Mawere C., Mutasa I., Kademeteme E., Maroyi A., Taderera T., Bhebhe M. Medicinal plants used for the management of respiratory diseases in Zimbabwe: review and perspectives potential management of COVID-19. Phys. Chem. Earth. 2022;128 doi: 10.1016/j.pce.2022.103232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pce.2022.103232</ArticleId><ArticleId IdType="pmc">PMC9489988</ArticleId><ArticleId IdType="pubmed">36161239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunrinola O.O., Kanmodi R.I., Ogunrinola O.A. Medicinal plants as immune booster in the palliative management of viral diseases: a perspective on coronavirus. Food Frontiers. 2022;3(Issue 1) doi: 10.1002/fft2.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fft2.107</ArticleId></ArticleIdList></Reference><Reference><Citation>Oladele J.O., Ajayi E.I., Oyeleke O.M., Oladele O.T., Olowookere B.D., Adeniyi B.M., Oyewole O.I., Oladiji A.T. A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants. Heliyon. 2020;6(9) doi: 10.1016/j.heliyon.2020.e04897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e04897</ArticleId><ArticleId IdType="pmc">PMC7480258</ArticleId><ArticleId IdType="pubmed">32929412</ArticleId></ArticleIdList></Reference><Reference><Citation>Saliu T.P., Umar H.I., Ogunsile O.J., Okpara M.O., Yanaka N., Elekofehinti O.O. Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16) J. Genet. Eng. Biotechnol. 2021;19(1) doi: 10.1186/s43141-021-00273-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43141-021-00273-5</ArticleId><ArticleId IdType="pmc">PMC8576800</ArticleId><ArticleId IdType="pubmed">34751829</ArticleId></ArticleIdList></Reference><Reference><Citation>Boozari M., Hosseinzadeh H. Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytother Res. 2021;35(Issue 2) doi: 10.1002/ptr.6873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6873</ArticleId><ArticleId IdType="pubmed">32985017</ArticleId></ArticleIdList></Reference><Reference><Citation>Pranskuniene Z., Balciunaite R., Simaitiene Z., Bernatoniene J. Herbal medicine uses for respiratory system disorders and possible trends in new herbal medicinal recipes during COVID-19 in pasvalys district, Lithuania. Int. J. Environ. Res. Publ. Health. 2022;19(15) doi: 10.3390/ijerph19158905.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19158905</ArticleId><ArticleId IdType="pmc">PMC9332438</ArticleId><ArticleId IdType="pubmed">35897276</ArticleId></ArticleIdList></Reference><Reference><Citation>Mlozi S.H. The role of natural products from medicinal plants against COVID-19: traditional medicine practice in Tanzania. Heliyon. 2022;8(6) doi: 10.1016/j.heliyon.2022.e09739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e09739</ArticleId><ArticleId IdType="pmc">PMC9212986</ArticleId><ArticleId IdType="pubmed">35747321</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda A.K., Kar S., Rai A.K., Rao B.C.S., Srikanth N. AYUSH- 64: a potential therapeutic agent in COVID-19. J. Ayurveda Integr. Med. 2022;13(Issue 2) doi: 10.1016/j.jaim.2021.100538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaim.2021.100538</ArticleId><ArticleId IdType="pmc">PMC8723836</ArticleId><ArticleId IdType="pubmed">35002178</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent S., Arokiyaraj S., Saravanan M., Dhanraj M. Molecular docking studies on the anti-viral effects of compounds from Kabasura kudineer on SARS-CoV-2 3CLpro. Front. Mol. Biosci. 2020;7 doi: 10.3389/fmolb.2020.613401.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2020.613401</ArticleId><ArticleId IdType="pmc">PMC7785853</ArticleId><ArticleId IdType="pubmed">33425994</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehzadi S., Khan S.M., Mustafa G., Abdullah A., Khan I., Ahmad Z., Han H., Yu J., Park J., Raposo A. Antiviral COVID-19 protein and molecular docking: in silico characterization of various antiviral compounds extracted from Arisaema jacquemontii Blume. Front. Public Health. 2022;10 doi: 10.3389/fpubh.2022.964741.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.964741</ArticleId><ArticleId IdType="pmc">PMC9540392</ArticleId><ArticleId IdType="pubmed">36211701</ArticleId></ArticleIdList></Reference><Reference><Citation>Adejoro I.A., Babatunde D.D., Tolufashe G.F. Molecular docking and dynamic simulations of some medicinal plants compounds against SARS-CoV-2: an in silico study. J. Taibah Univ. Sci. 2020;14(1) doi: 10.1080/16583655.2020.1848049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16583655.2020.1848049</ArticleId></ArticleIdList></Reference><Reference><Citation>Alagu Lakshmi S., Shafreen R.M.B., Priya A., Shunmugiah K.P. Ethnomedicines of Indian origin for combating COVID-19 infection by hampering the viral replication: using structure-based drug discovery approach. J. Biomol. Struct. Dyn. 2021;39(13) doi: 10.1080/07391102.2020.1778537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1778537</ArticleId><ArticleId IdType="pmc">PMC7332876</ArticleId><ArticleId IdType="pubmed">32573351</ArticleId></ArticleIdList></Reference><Reference><Citation>Solo P., doss M.A. Potential inhibitors of SARS-CoV-2 (COVID 19) spike protein of the delta and delta plus variant: in silico studies of medicinal plants of North-East India. Current Research in Pharmacology and Drug Discovery. 2021;2 doi: 10.1016/j.crphar.2021.100065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crphar.2021.100065</ArticleId><ArticleId IdType="pmc">PMC8530778</ArticleId><ArticleId IdType="pubmed">34870160</ArticleId></ArticleIdList></Reference><Reference><Citation>Shawky E., Nada A.A., Ibrahim R.S. Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses. RSC Adv. 2020;10(47) doi: 10.1039/d0ra05126h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/d0ra05126h</ArticleId><ArticleId IdType="pmc">PMC9055652</ArticleId><ArticleId IdType="pubmed">35519104</ArticleId></ArticleIdList></Reference><Reference><Citation>Burley S.K., Bhikadiya C., Bi C., Bittrich S., Chao H., Chen L., Craig P.A., Crichlow G.v., Dalenberg K., Duarte J.M., Dutta S., Fayazi M., Feng Z., Flatt J.W., Ganesan S.J., Ghosh S., Goodsell D.S., Green R.K., Guranovic V.…Zardecki C. RCSB Protein Data bank: tools for visualizing and understanding biological macromolecules in 3D. Protein Sci. : A Publication of the Protein Society. 2022;31(12) doi: 10.1002/pro.4482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4482</ArticleId><ArticleId IdType="pmc">PMC9667899</ArticleId><ArticleId IdType="pubmed">36281733</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair S.S.K., Bibi A., Al-Mahrami N., Satam P.M., Al Farsi A., Al Mawali A., Nallusamy S. PlantMedOman: a comprehensive online database for Oman's medicinal plants. Bioinformation. 2024;20(4) doi: 10.6026/973206300200314.</Citation><ArticleIdList><ArticleId IdType="doi">10.6026/973206300200314</ArticleId><ArticleId IdType="pmc">PMC11161888</ArticleId><ArticleId IdType="pubmed">38854754</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherwani N., Sulaiman A K., A. Farooq S. An ethnobotanical study of indigenous medicinal plants of Oman. Asian Journal of Scientific Research. 2021;14(2) doi: 10.3923/ajsr.2021.43.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.3923/ajsr.2021.43.56</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller W.E.G., Neufurth M., Schepler H., Wang S., Tolba E., Schröder H.C., Wang X. The biomaterial polyphosphate blocks stoichiometric binding of the SARS-CoV-2 S-protein to the cellular ACE2 receptor. Biomater. Sci. 2020;8(23) doi: 10.1039/d0bm01244k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/d0bm01244k</ArticleId><ArticleId IdType="pubmed">33231598</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapan C. v, Lundblad R.L., Price N.C. Colorimetric protein assay techniques. Biotechnol. Appl. Biochem. 1999;29(Pt 2)</Citation><ArticleIdList><ArticleId IdType="pubmed">10075906</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu C., Wu Y., Guo H., Zhu Y., Xu W., Wang Y., Zhou Y., Sun Z., Cai X., Li Y., Liu J., Huang Z., Yuan Z., Zhang R., Deng Q., Qu D., Xie Y. Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2. Sci. Bull. 2021;66(9) doi: 10.1016/j.scib.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scib.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7724564</ArticleId><ArticleId IdType="pubmed">33318880</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Deng Y., Zheng Z., Huang W., Chen L., Tong Q., Ming Y. Corilagin, a promising medicinal herbal agent. Biomed. Pharmacother. 2018;99 doi: 10.1016/j.biopha.2018.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.01.030</ArticleId><ArticleId IdType="pubmed">29324311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah A., Ullah S., Halim S.A., Waqas M., Ali B., Ataya F.S., El-Sabbagh N.M., Batiha G.E.S., Avula S.K., Csuk R., Khan A., Al-Harrasi A. Identification of new pharmacophore against SARS-CoV-2 spike protein by multi-fold computational and biochemical techniques. Sci. Rep. 2024;14(1) doi: 10.1038/s41598-024-53911-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-53911-6</ArticleId><ArticleId IdType="pmc">PMC10864406</ArticleId><ArticleId IdType="pubmed">38351259</ArticleId></ArticleIdList></Reference><Reference><Citation>Waqas M., Ullah S., Halim S.A., Rehman N.U., Ali A., Jan A., Muhsinah A. bin, Khan A., Al-Harrasi A. Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2. Int. J. Biol. Macromol. 2024;258 doi: 10.1016/j.ijbiomac.2023.128812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2023.128812</ArticleId><ArticleId IdType="pubmed">38114011</ArticleId></ArticleIdList></Reference><Reference><Citation>Waqas M., Ullah A., Ullah S., Halim S.A., Rehman N.U., Khalid A., Ali A., Khan S., Gibbons R., Al-Harrasi Csuk A. Disrupting protease and deubiquitinase activities of SARS-CoV-2 papain-like protease by natural and synthetic products discovered through multiple computational and biochemical approaches. Int. J. Biol. Macromol. 2024;277 doi: 10.1016/j.ijbiomac.2024.134476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2024.134476</ArticleId><ArticleId IdType="pubmed">39111477</ArticleId></ArticleIdList></Reference><Reference><Citation>Waqas M., Ullah S., Halim S.A., Ullah I., Rehman N.U., Jan A., Khalid A., Ali A., Khan A., Al-Harrasi A. Discovery of novel natural inhibitors against SARS-CoV-2 main protease: a rational approach to antiviral therapeutics. Curr. Med. Chem. 2024 doi: 10.2174/0109298673292839240329081008.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0109298673292839240329081008</ArticleId><ArticleId IdType="pubmed">38591207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>